AL
ENTA icon

Airain Ltd’s Enanta Pharmaceuticals ENTA Stock Holding History

Airain Ltd’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,325
Closed -$212K – 850
2016
Q4 		$212K Sell
6,325
-11,661
-65% -$334K 0.02% 588
2016
Q3 		$479K Buy
+17,986
New +$418K 0.03% 441
2015
Q4 		– Sell
-6,289
Closed -$227K – 895
2015
Q3 		$227K Sell
6,289
-13,366
-68% -$574K 0.01% 671
2015
Q2 		$884K Sell
19,655
-9,891
-33% -$385K 0.05% 387
2015
Q1 		$905K Buy
29,546
+22,865
+342% +$890K 0.06% 338
2014
Q4 		$340K Sell
6,681
-11,127
-62% -$498K 0.03% 466
2014
Q3 		$705K Buy
+17,808
New +$710K 0.05% 382

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
MCM
Matarin Capital Management New York $409M AUM 33.03% 1-Year Est. Return

Airain Ltd's ENTA Position: Q1 2017 in Review

Airain Ltd sold out of Enanta Pharmaceuticals (ENTA) in Q1 2017, closing a stake of 6,325 shares — an estimated $212K sold.

Airain Ltd first reported a position in ENTA in Q3 2014 and held it in 7 quarters. The position peaked at $905K in Q1 2015. 126 funds tracked by Wall St. Rank hold ENTA as of Q1 2017.

  • Airain Ltd reported no remaining Enanta Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Airain Ltd sold 6,325 Enanta Pharmaceuticals shares in Q1 2017, an estimated $212K.
  • Airain Ltd first reported a position in Enanta Pharmaceuticals in Q3 2014 and held it in 7 quarters.
  • Airain Ltd's Enanta Pharmaceuticals position peaked at $905K in Q1 2015.
  • 126 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2017.

Based on Airain Ltd's 13F filing for Q1 2017, filed 9 May 2017.